Get Live Data

Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Ip Group Share Price
  4. Ip Group Share Regulatory News
  5. Transaction in Own Shares

Pin to quick picksIp Group Regulatory News (IPO)

Ip Group Information

Share Price Information for Ip Group (IPO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 45.95
Bid: 45.30
Ask: 45.80
Change: 0.10 (0.22%)
Spread: 0.50 (1.104%)
Open: 46.75
High: 46.75
Low: 44.90
Prev. Close: 45.85
IPO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Transaction in Own Shares

30 Apr 2024 07:00

RNS Number : 4908M
IP Group PLC
30 April 2024
 

Transaction in Own Shares

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group"), today announces that Numis Securities Limited (which is trading for these purposes as Deutsche Numis) ("Deutsche Numis"), purchased on behalf of IP Group the number of ordinary shares of 2 pence each on the London Stock Exchange as set out in the table below (the Repurchased Shares) pursuant to the IP Group share buyback programme announced on 18th December 2023 (the Buyback Programme).

Date of purchase:

29/04/2024

Number of ordinary shares purchased:

129,885

Highest price paid per ordinary share (GBp):

49.50

Lowest price paid per ordinary share (GBp): 

48.80

Volume weighted average price paid per ordinary share (GBp): 

49.0897

 

The Group will hold the Repurchased Shares in treasury. Following the above transaction, the Group holds 31,753,534 of its ordinary shares in treasury and has 1,063,188,005 ordinary shares in issue (including treasury shares). Therefore, the total number of ordinary shares with voting rights will be 1,031,434,471 which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, IP Group under the FCA's Disclosure Guidance and Transparency Rules.

 

IP Group will make further announcements following the completion of any additional purchases pursuant to the Buyback Programme.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the purchases made by Deutsche Numis on behalf of IP Group as part of the Buyback Programme.

 

Both aggregate data in respect of the Repurchased Shares as well as the individual purchases are set out below.

 

Aggregate information:

 

Issuer name and ISIN: IP Group plc (ISIN: GB00B128J450)

 

Date of purchases:

29/04/2024

Number of ordinary shares purchased:

129,885

Volume weighted average price (pence):

49.0897

 

Individual transactions:

 

Number of ordinary shares purchased

Transaction price(GBp share)

Time of transaction (UK Time)

Trading venue

5093

49.05

 10:28:58

XLON

5765

48.85

 10:32:36

XLON

6493

48.80

 10:32:45

XLON

5456

49.00

 13:24:40

XLON

536

49.15

 13:24:40

XLON

5341

49.00

 13:25:33

XLON

416

49.00

 13:25:37

XLON

5695

49.00

 13:25:37

XLON

1468

49.00

 13:27:33

XLON

758

49.00

 13:27:33

XLON

1090

49.00

 13:27:33

XLON

565

49.00

 13:27:33

XLON

1090

49.00

 13:27:33

XLON

565

49.00

 13:27:33

XLON

1090

49.00

 13:27:33

XLON

565

49.00

 13:27:33

XLON

6027

48.90

 13:33:43

XLON

779

48.80

 14:15:01

XLON

4593

48.80

 14:15:01

XLON

385

48.80

 14:15:01

XLON

2700

48.80

 14:15:01

XLON

3033

48.80

 14:15:01

XLON

712

49.10

 15:30:45

XLON

369

49.10

 15:30:45

XLON

712

49.10

 15:30:45

XLON

369

49.10

 15:30:45

XLON

712

49.10

 15:30:45

XLON

369

49.10

 15:30:45

XLON

712

49.10

 15:31:41

XLON

4146

49.10

 15:31:41

XLON

2087

49.10

 15:35:43

XLON

2077

49.10

 15:35:43

XLON

2077

49.10

 15:35:43

XLON

1064

49.10

 15:35:43

XLON

456

49.10

 15:35:43

XLON

380

49.10

 15:35:43

XLON

2077

49.10

 15:35:43

XLON

462

49.10

 15:35:43

XLON

602

49.10

 15:35:43

XLON

456

49.10

 15:35:43

XLON

380

49.10

 15:35:43

XLON

1905

49.05

 15:40:07

XLON

493

49.05

 15:40:07

XLON

423

49.05

 15:40:07

XLON

352

49.05

 15:40:07

XLON

280

49.10

 15:41:21

XLON

987

49.10

 15:41:21

XLON

352

49.10

 15:41:21

XLON

423

49.10

 15:41:21

XLON

633

49.10

 15:41:21

XLON

1125

49.10

 15:41:21

XLON

482

49.10

 15:41:21

XLON

401

49.10

 15:41:21

XLON

2170

49.10

 15:41:21

XLON

1125

49.10

 15:41:21

XLON

401

49.10

 15:41:21

XLON

482

49.10

 15:41:21

XLON

2799

49.10

 15:44:13

XLON

285

49.45

 15:55:31

XLON

2030

49.50

 15:58:16

XLON

1388

49.50

 15:58:16

XLON

1388

49.50

 15:58:16

XLON

1388

49.50

 15:58:16

XLON

5684

49.50

 15:58:30

XLON

5535

49.35

 16:06:06

XLON

793

49.15

 16:13:12

XLON

793

49.15

 16:14:16

XLON

3000

49.35

 16:16:17

XLON

1048

49.35

 16:16:48

XLON

3000

49.35

 16:16:48

XLON

3000

49.35

 16:18:48

XLON

499

49.35

 16:18:48

XLON

1586

49.20

 16:27:07

XLON

3913

49.20

 16:27:07

XLON

 

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

Liz Vaughan-Adams, Communications

+44 (0) 20 7444 0062/+44 (0) 7967 312125

Portland

Alex Donaldson

+44 (0) 7516 729702

 

Further information on IP Group is available on our website: www.ipgroupplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSZZGZDRLRGDZM
456789101112
Date   Source Headline
4th Mar 20216:07 pmRNSHolding(s) in Company
2nd Mar 202112:03 pmRNSHolding(s) in Company
24th Feb 202110:33 amRNSNotice of Results
18th Feb 20214:31 pmRNSHolding(s) in Company
18th Feb 20218:00 amRNSHolding(s) in Company
17th Feb 20217:00 amRNSPortfolio company ApcinteX acquired by Centessa
10th Feb 20217:00 amRNSIP Group, Inc. raises $50.0m (£36.5m*) of funding
9th Feb 20213:52 pmRNSHolding(s) in Company
2nd Feb 20215:15 pmRNSHolding(s) in Company
11th Jan 20215:29 pmRNSHolding(s) in Company
6th Jan 20214:57 pmRNSPortfolio co Hinge Health completes $300m round
6th Jan 202111:34 amRNSHolding(s) in Company
6th Jan 20217:00 amRNSPortfolio co Oxbotica completes £36m funding round
4th Dec 202011:41 amRNSHolding(s) in Company
3rd Dec 20208:01 amRNSArtios and Merck in global strategic collaboration
25th Nov 20207:00 amRNSDirector Declaration
23rd Nov 20205:05 pmRNSHolding(s) in Company
21st Oct 20207:00 amRNSInvestor webinar
13th Oct 20207:00 amRNSOxford Nanopore funding round and contract win
9th Oct 20209:46 amRNSOxford Nanopore's LamPORE test gains CE-IVD mark
7th Oct 20207:00 amRNSEnterprise Therapeutics' program acquired by Roche
23rd Sep 20201:40 pmRNSHolding(s) in Company
15th Sep 202012:07 pmRNSSecond Price Monitoring Extn
15th Sep 202012:02 pmRNSPrice Monitoring Extension
7th Sep 202012:07 pmRNSSecond Price Monitoring Extn
7th Sep 202012:02 pmRNSPrice Monitoring Extension
1st Sep 20205:18 pmRNSForm 8.3 - Modern Water plc
5th Aug 20207:00 amRNSHalf-yearly results
3rd Aug 20207:00 amRNSNanopore partners with govt on covid-19 test
30th Jul 202012:08 pmRNSSecond Price Monitoring Extn
30th Jul 202012:02 pmRNSPrice Monitoring Extension
29th Jul 20209:45 amRNSHolding(s) in Company
28th Jul 20202:44 pmRNSNotice of Results
14th Jul 20201:29 pmRNSIP Group sells 9.16m shares in Ceres Power
14th Jul 20207:00 amRNSResult of secondary placing in Ceres Power
13th Jul 20205:11 pmRNSProposed secondary placing in Ceres Power Holdings
6th Jul 202012:02 pmRNSPrice Monitoring Extension
6th Jul 20207:00 amRNSAppoints Prof. Clark Chair of ESG Ethics Committee
3rd Jul 202012:07 pmRNSSecond Price Monitoring Extn
3rd Jul 202012:02 pmRNSPrice Monitoring Extension
24th Jun 20202:39 pmRNSHolding(s) in Company
24th Jun 20208:10 amRNSHolding(s) in Company
23rd Jun 202011:37 amRNSLTIP & DBSP awards; Director/PDMR shareholding
18th Jun 20202:05 pmRNSResult of AGM
18th Jun 20207:00 amRNSAGM Statement
9th Jun 20205:47 pmRNSAGM update
5th Jun 20206:28 pmRNSHolding(s) in Company
26th May 202010:05 amRNSInivata receives $25m investment from NeoGenomics
26th May 20207:00 amRNSOxford Nanopore announces £48.4m of new funding
22nd May 20207:00 amRNSOxford Nanopore in development of covid19 test
456789101112

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.